Funding for this research was provided by:
ConTIPI Medical Ltd.
Article History
Received: 26 June 2023
Accepted: 6 October 2023
First Online: 26 October 2023
Declarations
:
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Elan Ziv and Tsvia Erlich have financial interests with ConTIPI Medical Ltd. Nathan Keller has no financial interests to declare.
: The study received ethical approval from a central Institutional Review Board in the US (Pro00022375, July 26, 2017) and the Assuta Health System Ethics Committee/Institutional Review Board (#2016028, July 23, 2017) in Israel. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and its later amendments. This study does not contain any studies with animal subjects performed by any of the authors. <b>Clinical trial registry</b>: ClinicalTrials.gov (ExternalRef removed; No. NCT03345121; Registration date, November 17, 2017; initial enrollment started on August 20, 2017).
: Informed consent was obtained from all individual participants included in the study.